What NMN dose should a 70-year-old take? 1000 mg/day is reasonable, alongside comprehensive medical care.
This guide explains the rationale, gives you a precise protocol, and covers the edge cases (timing with food, fasting, other supplements, and personal variability) so you can dose NMN with confidence.
NAD+ (nicotinamide adenine dinucleotide) is a redox coenzyme present in every cell. It powers mitochondrial ATP production via the electron-transport chain, fuels DNA-repair enzymes (PARPs), and is the obligatory substrate for sirtuins (SIRT1–SIRT7) — the enzyme family that controls gene expression, inflammation, and cellular survival.
NAD+ levels fall by 50% or more between ages 30 and 60. That decline is now considered a leading mechanistic explanation for age-related metabolic dysfunction, mitochondrial fatigue, accumulation of senescent cells, and the loss of muscle, skin, and cognitive resilience seen in aging.
NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are the two NAD+ precursors with the strongest human data. Both raise NAD+ via the salvage pathway: NR is phosphorylated by NRK1/NRK2 to form NMN, then converted to NAD+; NMN is dephosphorylated to NR for cellular uptake or — per Imai's lab — taken up directly through the Slc12a8 transporter in mouse small intestine. NADH is the reduced electron-carrying form. Niacinamide (nicotinamide) and niacin (nicotinic acid) are cheaper but raise NAD+ less efficiently, and high-dose nicotinamide (>1 g/day) inhibits sirtuins.
CD38, an NAD+-degrading enzyme, rises with age. Inhibitors of CD38 — apigenin, quercetin, luteolin — preserve the NAD+ you make. Methylation cofactors (TMG, B12, folate) become depleted with high-dose precursor use because the body methylates excess nicotinamide for excretion.
Why this dose works. By age 70, NAD+ has fallen ~60% from young-adult levels. Higher precursor doses may be needed. Coordinate with primary care given likelihood of multiple medications.
Clinical context. Most NMN human trials cluster between 250–1250 mg/day. The Yoshino 2021 NEJM trial used 250 mg over 10 weeks and showed muscle insulin-sensitivity improvement. The Yamaguchi 2022 dose-ranging trial showed dose-dependent NAD+ rises through 1250 mg without serious adverse events. The Martens 2018 NR trial used 500 mg twice daily for 6 weeks with sustained NAD+ elevation.
Exact protocol. 1000 mg/day (split 500 AM + 500 lunch) + TMG 1000 mg + B-complex + apigenin 50 mg PM + standard medical care. Discuss with physician given polypharmacy considerations.
Stack notes. Always pair high-dose NMN (>500 mg) with TMG to support methylation. Add apigenin 50 mg PM to inhibit CD38. Consider methylated B-complex if your diet is not B-rich.
What to monitor. Subjective energy, sleep quality, recovery from exercise. Optional NAD+ blood test at 8 weeks (Jinfiniti) for objective verification.
What if I miss a dose of NMN?
Skip the missed dose and resume normal schedule the next day. Don't double-dose. NAD+ uplift is gradual and one missed dose has no meaningful long-term effect.
How long until NMN dosing produces measurable NAD+ rise?
Cellular NAD+ rises within days of starting; subjective effects appear over 4–8 weeks; blood NAD+ stabilizes at 6–12 weeks.
Can I take NMN with my prescription medications?
NMN has few documented interactions. Always disclose to your prescriber, especially if you take blood thinners, diabetes medication, or chemotherapy.